Our Businesses
Our Company
Sustainability
e invite our suppliers to work alongside us to create a multiplier effect in communities across the globe. Our award-winning Supplier Sustainability Program is key to this effort, helping to drive continuous improvements in reducing environmental impact and improving human rights. By 2025, we aim to expand our Supplier Sustainability Program to include all suppliers.
We recognize that, to create impact at scale, we must be clear about our requirements and help our suppliers incorporate sustainable practices into their business. We verify and monitor supplier compliance with our Responsibility Standards for Suppliers through formal assessment and audits.
EcoVadis provides business sustainability ratings, intelligence and collaborative performance improvement tools for global supply chains. Suppliers in Johnson & Johnson's Supplier Sustainability Program are required to complete an EcoVadis assessment and work on continual improvements to ensure they uphold our Responsibility Standards for Suppliers.
CDP is a not-for-profit organization that provides the global disclosure system for investors, companies, cities, states and regions to manage environmental impacts. CDP Supply Chain tracks the climate, water and forest footprint of an organization. Johnson & Johnson discloses to CDP and requests certain suppliers do the same.
Our Human Rights in the Supply Base Program was established to ensure we are upholding human rights throughout our supply chain. Our goal is to assess labor practices in the supply base and work with our suppliers to ensure the human rights elements of our Responsibility Standards for Suppliers are upheld.
A Partnership for Good is a collaboration between Johnson & Johnson and a supplier to create innovative solutions that drive significant environmental, social and economic improvements. Partnership for Good projects are directly tied to Johnson & Johnson’s sustainability priorities. By 2025, we intend to establish 10 supplier Partnerships for Good.
More from Johnson & Johnson
-
Johnson & Johnson's Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That's where he met Tiko Kerr, who became one of the first patients to take the company's HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
-
Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.
-
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
